Bevacizumab and atrial fibrillation 
Bevacizumab and atrial fibrillation Patient Reports February 10, 2012
Bevacizumab Side Effects Report #6016813-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Male patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, atrial fibrillation , brain natriuretic peptide increased, cardio-respiratory arrest, hypervolaemia, hypoxia, lung infiltration, perirectal abscess, troponin i increased. Bevacizumab dosage: 10 MG/KG, DAYS 1 + 15/28DC. During the same period patient was treated with TEMSIROLIMUS, LISINOPRIL. Patient was hospitalized. Patient died on 05/16/2008.Bevacizumab Side Effects Report #6072864-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 02, 2009. Male patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, muscular weakness, renal failure. Bevacizumab dosage: 5 MG/KG, DAYS 1+15. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5990869-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with renal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cerebral ischaemia, wound dehiscence. Bevacizumab dosage: 5 MG/M2, Q2W. During the same period patient was treated with BAY. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5166002-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2006. Male patient, 71 years of age, was diagnosed with prostate cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, aortic valve incompetence, atrial fibrillation
, dilatation ventricular, haematochezia, mitral valve incompetence, neutropenia, pulmonary valve incompetence, rectal haemorrhage. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, PREDNISONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4749881-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 01, 2005. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, atrial fibrillation , subarachnoid haemorrhage. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PROVENGE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4778294-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 13, 2005. Female patient, 48 years of age, weighting 222.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, activated partial thromboplastin time prolonged, adhesion , ascites, atelectasis, atrial fibrillation , blood creatine phosphokinase increased, blood creatinine increased, blood lactic acid decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOL, DOCUSATE, SENNA, ESTROGENIC HORM SUBSTANCES, WARFARIN, LISINOPRIL, EPOETIN ALFA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4790315-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 26, 2005. Female patient, 48 years of age, weighting 222.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal adhesions, activated partial thromboplastin time prolonged, ascites, atelectasis, atrial fibrillation
, blood creatinine increased, blood ph decreased, blood sodium decreased, collapse of lung. Bevacizumab dosage: unknown. During the same period patient was treated with TAXOL, DOCUSATE, SENNA, ESTROGENIC HORM SUBSTANCES, WARFARIN, LISINOPRIL, EPOETIN ALFA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4848559-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 22, 2005. Female patient, 48 years of age, weighting 222.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, atelectasis, atrial fibrillation
, blood creatine increased, blood creatine phosphokinase increased, blood sodium decreased, blood urea increased, cardiac failure high output, collapse of lung. Bevacizumab dosage: unknown. During the same period patient was treated with TAXOL, DOCUSATE, SENNA, ESTROGENIC HORM SUBSTANCES, WARFARIN, LISINOPRIL, EPOETIN ALFA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4899738-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 17, 2006. Female patient, 48 years of age, weighting 222.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal adhesions, activated partial thromboplastin time prolonged, asthenia, atelectasis, atrial fibrillation
, blood creatine phosphokinase increased, blood lactic acid increased, blood ph decreased, blood sodium decreased. Bevacizumab dosage: UNK, Q3W; INTRAVENOUS; 15MG/KG, Q3W;. During the same period patient was treated with SENNA, ESTROGENIC HORM SUBSTANCES, WARFARIN, LISINOPRIL, EPOETIN ALFA, PREDNISONE, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5698120-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2008. Female patient, weighting 244.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, supraventricular tachycardia. Bevacizumab dosage: 1647 MG, Q3W. During the same period patient was treated with AMLODIPINE, ATIVAN, KETOPROFEN, PIROXICAM, BACLOFEN, LEVOXYL, METOPROLOL TARTRATE, PERCOCET. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5508187-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 29, 2007. Male patient, 73 years of age, weighting 78.93 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, fatigue. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, IMODIUM, REGLAN, NORVASC, LIPITOR, MEGACE, NYSTATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5557421-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 10, 2007. Male patient, 73 years of age, weighting 78.93 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, condition aggravated, fatigue, melaena. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, IMODIUM, REGLAN, NORVASC, LIPITOR, MEGACE, NYSTATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5594690-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, VALIUM, PROTONIX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5595193-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, atrial fibrillation
, dehydration, sepsis . Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, OXYCODONE, VALIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5601543-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 17, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, atrial fibrillation
, dehydration, sepsis . Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, PROTONIX, LORTAB, OXYCODONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5756120-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 28, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma, type 2 diabetes mellitus, hypertension, coronary artery disease
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation . Bevacizumab dosage: 1200 MG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL, GLIPIZIDE, BENAZEPRIL HYDROCHLORIDE, PLAVIX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5759290-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 30, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma, type 2 diabetes mellitus, hypertension, coronary artery disease
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation . Bevacizumab dosage: 1200 MG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL, GLIPIZIDE, BENAZEPRIL HYDROCHLORIDE, PLAVIX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5782996-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 18, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma, type 2 diabetes mellitus, hypertension, coronary artery disease
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation . Bevacizumab dosage: 1200 MG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL, GLIPIZIDE, BENAZEPRIL HYDROCHLORIDE, PLAVIX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5370535-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 21, 2007. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, deep vein thrombosis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO, CHLORTHIAZIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5586042-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 03, 2008. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, deep vein thrombosis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO, CHLORTHIAZIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5868154-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 25, 2008. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, deep vein thrombosis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, LANTUS, INSULIN LISPRO, CHLORTHIAZIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6039223-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 08, 2009. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, deep vein thrombosis , pneumonia , vomiting. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO. Patient was hospitalized. Patient died on 04/08/2007.Bevacizumab Side Effects Report #6075890-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 05, 2009. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, deep vein thrombosis , pneumonia , vomiting. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5449350-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 29, 2007. Female patient, weighting 121.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 864 MG, UNK. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5469596-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 12, 2007. Male patient, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, atrial fibrillation
. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, SERETIDE, SPIRIVA, TRANXENE, LIPANTHYL, ATARAX, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5565747-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 06, 2007. Male patient, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, atrial fibrillation
. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, SERETIDE, SPIRIVA, TRANXENE, FENOFIBRATE, ATARAX, LANZOR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5584606-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Female patient, weighting 178.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation
, tremor. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ZYRTEC, HYDROXYZINE, SINGULAIR, REGLAN, BONIVA, CELEBREX, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5888440-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 10, 2008. Male patient, weighting 208.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: unknown. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5901744-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 23, 2008. Male patient, weighting 208.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, ALIMTA, FERROUS GLUCONATE, SIROLIMUS, FLUVASTATIN, OXYCODONE, MYCOPHENOLATE MOFETIL, METOPROLOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5926993-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 16, 2008. Male patient, weighting 178.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with GEMCITABINE, PEMETREXED. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5935628-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 24, 2008. Male patient, weighting 178.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with GEMCITABINE, PEMETREXED. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5977890-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 25, 2008. Male patient, weighting 174.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, atrial fibrillation
, diarrhoea, sepsis , vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PEMETREXED, GEMCITABINE. Patient was hospitalized. Patient died on 11/25/2008.Bevacizumab Side Effects Report #5989130-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, chest pain , troponin t increased. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with CETUXIMAB, PACLITAXEL, CARBOPLATIN. Patient recovered.Bevacizumab Side Effects Report #6049470-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 16, 2009. Male patient, weighting 174.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, atrial fibrillation
, diarrhoea, sepsis , vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PEMETREXED, GEMCITABINE, LANOXIN, METOPROLOL TARTRATE, MAG OXIDE, PREDNISONE, ALPRAZOLAM, GLUCOSAMINE. Patient was hospitalized. Patient died on 11/25/2008.Bevacizumab Side Effects Report #6069582-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2009. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, pulmonary oedema, respiratory tract infection. Bevacizumab dosage: 15 MG/M2, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, SIMVASTATIN, CELIPROLOL, ASAFLOW, REDOMEX, ACETAMINOPHEN, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5950857-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2008. Male patient, weighting 179.9 lb, was diagnosed with malignant melanoma, metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 873 MG, UNK. During the same period patient was treated with ABRAXANE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5499798-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 23, 2007. Male patient, 78 years of age, was diagnosed with hepatic neoplasm malignant, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, hypertension. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, LISINOPRIL, LOSARTAN POTASSIUM, NADOLOL, NEXIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5522635-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 15, 2007. Male patient, 78 years of age, was diagnosed with hepatic neoplasm malignant, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, hypertension. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, LISINOPRIL, LOSARTAN POTASSIUM, NADOLOL, NEXIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5571103-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 18, 2007. Male patient, 78 years of age, was diagnosed with hepatic neoplasm malignant, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, hypertension. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, LISINOPRIL, LOSARTAN POTASSIUM, NADOLOL, NEXIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5763321-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 02, 2008. Male patient, 52 years of age, was diagnosed with head and neck cancer
, tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5813871-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 10, 2008. Male patient, 52 years of age, was diagnosed with head and neck cancer
, tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5821956-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 18, 2008. Male patient, 52 years of age, was diagnosed with head and neck cancer
, tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , syncope. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5530586-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 19, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: angina pectoris, arrhythmia
, atrial fibrillation , cardiac arrest , myocardial ischaemia, ventricular fibrillation. Bevacizumab dosage: 312.5 MG, Q2W. During the same period patient was treated with FOLINIC ACID, IRINOTECAN, FLUOROURACIL, DEXAMETHASONE, MOTILIUM, WARFARIN, ZOFRAN. Patient died on 01/19/2005.Bevacizumab Side Effects Report #5631412-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, blood glucose increased, cyanosis, gastrointestinal haemorrhage, hypotension, myocardial infarction, pancytopenia, peripheral coldness, renal failure. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with ERBITUX, LEUCOVORIN CALCIUM, OXALIPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 01/06/2008.Bevacizumab Side Effects Report #5671247-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 06, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: angina pectoris, arrhythmia
, atrial fibrillation , cardiac arrest , myocardial ischaemia, ventricular fibrillation. Bevacizumab dosage: 312.5 MG, Q2W. During the same period patient was treated with FOLINIC ACID, IRINOTECAN, FLUOROURACIL, DEXAMETHASONE, MOTILIUM, WARFARIN, ZOFRAN. Patient died on 01/19/2005.Bevacizumab Side Effects Report #5940419-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 22, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 360 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4670232-6
Bevacizumab side effect was reported by a Physician from on May 02, 2005. Male patient, 81 years of age, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, aspiration, atrial fibrillation , disease progression, hypotension, loss of consciousness, myocardial ischaemia, nausea , neutropenia. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, CALCIUM LEUCOVORIN, FLUOROURACIL. Patient was hospitalized. Patient died on 02/06/2003.Bevacizumab Side Effects Report #6014751-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 08, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure. Bevacizumab dosage: 5 MG, UNK. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5325441-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 01, 2007. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, confusional state, hyperglycaemia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5514771-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 01, 2007. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FOLINIC ACID, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5680955-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 11, 2008. Female patient, weighting 146.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 500 MG, Q3W. During the same period patient was treated with CAPECITABINE, GLUCOSAMINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5695902-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 25, 2008. Female patient, weighting 146.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 500 MG, Q3W. During the same period patient was treated with CAPECITABINE, GLUCOSAMINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5708219-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 02, 2008. Female patient, weighting 146.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 500 MG, Q3W. During the same period patient was treated with CAPECITABINE, GLUCOSAMINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5720515-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5814131-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 02, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 350 MG, UNK. During the same period patient was treated with GRANISETRON, IRINOTECAN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5831548-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 18, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, heart rate irregular. Bevacizumab dosage: 700 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, LEVOTHYROXINE, RAMIPRIL, ASPIRIN, LIPITOR, METOPROLOL, FENTANYL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5839040-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 24, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 700 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, LEVOTHYROXINE, RAMIPRIL, ASPIRIN, LIPITOR, METOPROLOL SUCCINATE, FENTANYL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5926041-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 06, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 700 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, LEVOTHYROXINE, RAMIPRIL, ASPIRIN, LIPITOR, METOPROLOL TARTRATE, FENTANYL CITRATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5533801-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 22, 2007. Female patient, weighting 172.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 1170 MG, DAYS 1+15. During the same period patient was treated with TAXOL, XELODA. Patient recovered.Bevacizumab Side Effects Report #5625270-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 07, 2008. Female patient, weighting 169.3 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with GEMCITABINE, PACLITAXEL, ASPIRIN, COMPAZINE, HYDROCHLOROTHIAZIDE, LISINOPRIL, VICODIN, ASCORBIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5641810-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 19, 2008. Female patient, weighting 169.3 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with GEMCITABINE, PACLITAXEL, ASPIRIN, COMPAZINE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5987402-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 03, 2008. Female patient, weighting 200.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, dyspnoea. Bevacizumab dosage: 925 MG, Q3W. During the same period patient was treated with ARIMIDEX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6029163-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 29, 2008. Female patient, weighting 200.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, dyspnoea. Bevacizumab dosage: 925 MG, Q3W. During the same period patient was treated with ARIMIDEX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5443251-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Female patient, 65 years of age, weighting 192.0 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , bronchitis , laryngitis, mental status changes, sepsis , sinusitis , vomiting. Bevacizumab dosage: 15MG/KG Q3WKS (IV). During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6025037-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 18, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, pulmonary hypertension , ventricular dysfunction. Bevacizumab dosage: 1220 MG, Q21D. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, PAROXETINE, PRAVASTATIN, LEVOTHYROX, APREPITANT, PREDNISOLONE. Patient recovered.Bevacizumab Side Effects Report #6042390-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 05, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, left ventricular dysfunction, pulmonary hypertension . Bevacizumab dosage: 1220 MG, Q21D. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, PAROXETINE, PRAVASTATIN, LEVOTHYROX, APREPITANT, PREDNISOLONE. Patient recovered.Bevacizumab Side Effects Report #6099159-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 18, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, left ventricular dysfunction. Bevacizumab dosage: 1220 MG, Q21D. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, PAROXETINE, PRAVASTATIN, LEVOTHYROX, APREPITANT, PREDNISOLONE. Patient recovered.Bevacizumab Side Effects Report #5440836-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Male patient, weighting 271.2 lb, was diagnosed with bile duct cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abscess
, alpha haemolytic streptococcal infection, arterial disorder, ascites, atelectasis, atrial fibrillation , blood bicarbonate decreased, blood chloride increased, blood culture positive. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, ALLEGRA, ATIVAN, WELLBUTRIN, CHONDROITIN, MOTRIN, LOVENOX. Patient was hospitalized. Patient died on 08/06/2007.Bevacizumab Side Effects Report #5931832-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 13, 2008. Female patient was diagnosed with adenocarcinoma pancreas and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient recovered.Bevacizumab Side Effects Report #6014977-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 10, 2008. Female patient was diagnosed with adenocarcinoma pancreas and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with GEMCITABINE, CISPLATIN, DILAUDID, NORVASC. Patient recovered.Bevacizumab Side Effects Report #6074408-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 27, 2009. Female patient, 79 years of age, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, tachyarrhythmia. Bevacizumab dosage: 328 MG, UNK. During the same period patient was treated with CAPECITABINE, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5650469-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 04, 2008. Male patient, weighting 205.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorectal discomfort, atrial fibrillation
, epistaxis, heart rate abnormal, international normalised ratio increased, pain , proctalgia, purulence, rectal haemorrhage. Bevacizumab dosage: 1920 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5662104-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2008. Male patient, weighting 205.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorectal discomfort, atrial fibrillation
, epistaxis, international normalised ratio increased, proctalgia, purulence, rectal haemorrhage, ulcer . Bevacizumab dosage: 1920 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN, COUMADIN. Patient was hospitalized. Patient recovered.